Xiamen Inno Medical Technology Co., Ltd., a China-based specialist in artificial intelligence (AI) powered digestive endoscopy, has entered into a partnership with Olympus Corporation, a major player in the digestive endoscopy field. The collaboration aims to explore innovative applications and development of AI technology within the digestive endoscopy sector. Financial details of the agreement were not disclosed.
Inno’s electronic-assisted detection software for gastrointestinal endoscopy images, which identifies intestinal polyps, recently received Category III device approval in China. The product, designed to enhance the detection rate of early cancer and precancerous lesions during digestive endoscopy exams with the aid of AI technology, includes features such as “lesion detection,” “lesion diagnosis,” and “surgical quality control.” It has been installed in over 200 hospitals both domestically and internationally, with no reported adverse events.- Flcube.com
